1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. Asia Pacific Cell and Gene Therapy Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. Asia Pacific Cell and Gene Therapy Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Increase in Number of Approval of Cell and Gene Therapies
- 5.1.2 Rapid Popularity of Outsourcing Cell and Gene Therapy Manufacturing
5.2 Market Opportunities
- 5.2.1 Strategic Initiatives by Companies
5.3 Future Trends
- 5.3.1 Automation of Cell and Gene Therapy Manufacturing Services
5.4 Impact of Drivers and Restraints
6. Asia Pacific Cell and Gene Therapy Market Regional Analysis
6.1 Asia Pacific Cell and Gene Therapy Market Overview
6.2 Asia Pacific Cell and Gene Therapy Market Revenue 2021-2031 (US$ Million)
6.3 Asia Pacific Cell and Gene Therapy Market Forecast Analysis
7. Asia Pacific Cell and Gene Therapy Market Analysis – by Type
7.1 Cell Therapy
- 7.1.1 Overview
- 7.1.2 Cell Therapy: Asia Pacific Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Gene Therapy
- 7.2.1 Overview
- 7.2.2 Gene Therapy: Asia Pacific Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
8. Asia Pacific Cell and Gene Therapy Market Analysis – by Services
8.1 Process Development
- 8.1.1 Overview
- 8.1.2 Process Development: Asia Pacific Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
8.2 cGMP Manufacturing
- 8.2.1 Overview
- 8.2.2 cGMP Manufacturing: Asia Pacific Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Regulatory Services
- 8.3.1 Overview
- 8.3.2 Regulatory Services: Asia Pacific Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
8.4 Bioassay Services
- 8.4.1 Overview
- 8.4.2 Bioassay Services: Asia Pacific Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
9. Asia Pacific Cell and Gene Therapy Market Analysis – by Scale
9.1 Pre Commercial/R
- 9.1.1 Overview
- 9.1.2 Bioassay Services: Asia Pacific Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
9.2 D Manufacturing
- 9.2.1 Overview
- 9.2.2 Bioassay Services: Asia Pacific Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
9.3 Commercial Scale Manufacturing
- 9.3.1 Overview
- 9.3.2 Bioassay Services: Asia Pacific Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
10. Asia Pacific Cell and Gene Therapy Market – Asia Pacific Analysis
10.1 Asia Pacific
- 10.1.1 Asia Pacific Cell and Gene Therapy Market Breakdown, by Key
Country, 2025 and 2031 (%)
- 10.1.1.1 Asia Pacific Cell and Gene Therapy Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 India:
Asia Pacific Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 10.1.1.1.1 India: Asia Pacific Cell and Gene Therapy Market Breakdown, by Type
- 10.1.1.1.2 India: Asia Pacific Cell and Gene Therapy Market Breakdown, by Services
- 10.1.1.1.3 India: Asia Pacific Cell and Gene Therapy Market Breakdown, by Scale
- 10.1.1.2 China:
Asia Pacific Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 10.1.1.2.1 China: Asia Pacific Cell and Gene Therapy Market Breakdown, by Type
- 10.1.1.2.2 China: Asia Pacific Cell and Gene Therapy Market Breakdown, by Services
- 10.1.1.2.3 China: Asia Pacific Cell and Gene Therapy Market Breakdown, by Scale
- 10.1.1.3 Japan:
Asia Pacific Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 10.1.1.3.1 Japan: Asia Pacific Cell and Gene Therapy Market Breakdown, by Type
- 10.1.1.3.2 Japan: Asia Pacific Cell and Gene Therapy Market Breakdown, by Services
- 10.1.1.3.3 Japan: Asia Pacific Cell and Gene Therapy Market Breakdown, by Scale
- 10.1.1.4 South Korea:
Asia Pacific Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 10.1.1.4.1 South Korea: Asia Pacific Cell and Gene Therapy Market Breakdown, by Type
- 10.1.1.4.2 South Korea: Asia Pacific Cell and Gene Therapy Market Breakdown, by Services
- 10.1.1.4.3 South Korea: Asia Pacific Cell and Gene Therapy Market Breakdown, by Scale
- 10.1.1.5 Australia:
Asia Pacific Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 10.1.1.5.1 Australia: Asia Pacific Cell and Gene Therapy Market Breakdown, by Type
- 10.1.1.5.2 Australia: Asia Pacific Cell and Gene Therapy Market Breakdown, by Services
- 10.1.1.5.3 Australia: Asia Pacific Cell and Gene Therapy Market Breakdown, by Scale
- 10.1.1.6 Rest of Asia Pacific:
Asia Pacific Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 10.1.1.6.1 Rest of Asia Pacific: Asia Pacific Cell and Gene Therapy Market Breakdown, by Type
- 10.1.1.6.2 Rest of Asia Pacific: Asia Pacific Cell and Gene Therapy Market Breakdown, by Services
- 10.1.1.6.3 Rest of Asia Pacific: Asia Pacific Cell and Gene Therapy Market Breakdown, by Scale
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Asia Pacific Cell and Gene Therapy Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 Catalent Inc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Charles River Laboratories International Inc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 F. Hoffmann-La Roche Ltd
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 FUJIFILM Holdings Corp
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Lonza Group AG
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Lotte Corp
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Merck KGaA
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Takara Bio Inc
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Thermo Fisher Scientific Inc.
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 WuXi AppTec Co Ltd
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
Get Free Sample For Asia Pacific Cell and Gene Therapy Market
